MedPath

Evaluation of association of Parkinsons Disease symptoms with urinary vesicles(exsomes).

Phase 3
Conditions
Health Condition 1: G20- Parkinsons disease
Registration Number
CTRI/2021/06/033946
Lead Sponsor
DrDinesh Upadhya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients will be enrolled from neurology OPD of Kasturba Hospital Manipal.

Patients satisfying the UK PD Brain Bank criteria for idiopathic PD will be included after clinical evaluation by a movement disorder specialist.

Criteria includes bradykinesia and at least 1 of the following

Muscular rigidity; 4-6Hz resting tremor; postural instability not caused by a primary visual

,vestibular,cerebellar or proprioceptive dysfunction following the exclusion of other causes of Parkinsonism.

Additionally, 3 or more features that supported a diagnosis of PD including: a unilateral onset and presence of a resting tremor, a progressive disorder,

Persistent asymmetry maximally affecting the side of onset,

Excellent response to levodopa and presence of severe levodopa induced chorea.

Exclusion Criteria

atypical Parkinsonism, secondary Parkinsonism,

h/o repeated Strokes, intake of antipsychotics,mini-mental state examination score <24, presence of cerebral tumor or communicating hydrocephalus,negative response to large doses of Levodopa(if malabsorption is excluded,exposure to 1-methyl4- phenyl2,3,6tetrahydropyridine(MPTP), patients who refused or were unable to give consent

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
In MDS UPDRS, extent and burden of PD will be measured.In MDS NMSS, severity and frequency of NMSs across 9 dimensions will be measured.In urinary Evs, total number of Evs, their size and concentration of proteins will be measured. <br/ ><br>The generated data will help us to understand the association between PD symptoms with urinary EV proteins. If we find a clear association with any specific parameter of EVs with NMS symptoms, further studies can be taken upTimepoint: Urinary exosomes will be isolated immediately.Isolated exosomes will be stored at -80 and analyzed in batches within a week.
Secondary Outcome Measures
NameTimeMethod
relation of non motor symptoms to motor symptoms will also be statistically analyzed.this will be done in a Tertiary care hospital setting in Manipal,KarnatakaTimepoint: Urinary exosomes will be isolated immediately.Isolated exosomes will be stored at -80 and analyzed in batches within a week. <br/ ><br>it will take 1.5 hours to fill up questionnaire and scale and data collected will be analyzed simultaneously <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath